Borderline Personality Disorder and ADHD: BI 3031185 Study

We are testing how well BI 3031185 is tolerated by individuals with borderline personality disorder or ADHD. This study aims to gather information on its safety and side effects.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Charite Research Organisation GmbH
Charité - Universitätsmedizin Berlin
Berlin, Germany
Universitaetsklinikum Bonn AöR
Klinik und Poliklinik für Psychiatrie und Psychotherapie
Bonn, Germany
Goethe University Frankfurt
Klinik für Psychiatrie, Psychosomatik und Psychotherapie
Frankfurt am Main, Germany

Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.